Traders expect the Federal Reserve to pause future rate rises, Bristol-Myers Squibb's $90bn takeover of Celgene signals a big year for pharma M&A and agricultural researchers discover a genetic breakthrough in crop growth. Then, why EU officials are looking to toughen scrutiny of potential security risks with Chinese technology companies. 

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast